These numbers matter because excess weight drives cardiovascular and metabolic disease, and a peptide that addresses both the weight and its consequences simultaneously delivers compounding health benefits
Before your visit You dont need to fast or prepare in any special way
Disclosure of interest: All authors have nothing to disclose Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P153 - ESOC25-601 MIDDLE MENINGEAL ARTERY EMBOLIZATION IN A COHORT OF PATIENTS ON ANTITHROMBOTIC THERAPY Eduardo Fandio 1 , Isabel Bermudez-Coronel 1 , Mara Prez 1 , Jose Carlos Mendez 1 , Rodrigo Carrasco 1 , Vctor Rodrguez 1 , Lara Castellanos 1 , Eva Cortina 1 , Karolina Monsior 1 , Luis Ley 1 1 Hospital Universitario Ramn y Cajal, Madrid, Spain Background and Aims: To evaluate the effectiveness and safety of middle meningeal artery embolization in chronic subdural hematoma patients on antithrombotic therapy
Counsel patients on the importance of returning for follow-up blood tests every 3 to 6 months to confirm adequacy of therapy [see Dosage and Administration (2.3)]
